Aesthetic Injectables Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Aesthetic Injectables Pipeline Market Report Overview
Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. The Aesthetic Injectables pipeline market research report provides comprehensive information about the aesthetic Injectables pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
| Key Segments | · Hyaluronic Acid Fillers
· Non-Hyaluronic Acid Fillers · Biphasic Hyaluronic Acid Fillers · Poly-L-Lactic Acid (PLLA) Fillers |
| Key Territories | · United States
· Europe · China · South Korea · Others |
| Key Regulatory Paths | · PMA
· CE · NMPA · NIFDS · 510(k) · BOPA · HSA · MDITAC · MDL · MDCO · ANVISA · ICAC · MDA · Ninsho · TGA · Shonin |
| Leading Companies | · AbbVie Inc
· BioPlus Co Ltd · Celltrix AB · Galderma SA · Others |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Aesthetic Injectables Pipeline Market Segments
Some of the key segments in the aesthetic Injectables pipeline market are Hyaluronic Acid Fillers, Non-Hyaluronic Acid Fillers, Biphasic Hyaluronic Acid Fillers, and Poly-L-Lactic Acid (PLLA) Fillers. As of May 2023, Hyaluronic Acid Fillers had the highest share.
Aesthetic Injectables Pipeline Market Analysis, by Segments, 2023 (%)
For more segment insights into the aesthetic Injectables pipeline market, download a free report sample
Aesthetic Injectables Pipeline Market Segmentation by Territories
Some key territories with aesthetic Injectables products in the pipeline are the US, Europe, China, South Korea, Israel, and Taiwan among others. As of May 2023, the US had the highest number of products in the pipeline compared to the other territories.
Aesthetic Injectables Pipeline Market Analysis, by Territories, 2023 (%)
For more territory insights into the aesthetic Injectables pipeline market, download a free report sample
Aesthetic Injectables Pipeline Market Segmentation by Regulatory Paths
Some of the key regulatory paths followed by the aesthetic Injectables pipeline products are PMA, CE, NMPA, NIFDS, 510 (k), BOPA, HAS, MDITAC, and MDL among others. As of May 2023, the mostly deployed regulatory path for aesthetic Injectables market was PMA.
Aesthetic Injectables Pipeline Market Analysis, by Regulatory Paths, 2023 (%)
For more regulatory path insights into the Aesthetic Injectables pipeline market, download a free report sample
Aesthetic Injectables Pipeline Market – Competitive Landscape
Some of the leading companies in the Aesthetic Injectables pipeline reconstruction market are AbbVie Inc, BioPlus Co Ltd, Celltrix AB, Galderma SA, Genzyme Corp, Medytox Inc, Teoxane SA, and Tissueform Inc among others.
AbbVie Inc Overview: AbbVie Inc (AbbVie) is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. Its drugs are indicated for the treatment of metabolic and rheumatological diseases, neurological disorders, skin diseases, rheumatoid arthritis, pain related to endometriosis, pediatric Crohn’s disease, cancer, and other serious health conditions. AbbVie is also advancing its pipeline programs for the treatment of Crohn’s disease, Parkinson’s disease, viral diseases, wet AMD, various cancers, neurological disorders, aesthetics, and other autoimmune diseases. The company markets its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses worldwide. AbbVie is headquartered in North Chicago, Illinois, the US.
Segments Covered in the Report
Aesthetic Injectables Pipeline Market Segments Outlook
- Hyaluronic Acid Fillers
- Non-Hyaluronic Acid Fillers
- Biphasic Hyaluronic Acid Fillers
- Poly-L-Lactic Acid (PLLA) Fillers
Aesthetic Injectables Pipeline Market Territories Outlook
- United States
- Europe
- China
- South Korea
- Global
- Israel
- Taiwan
- Singapore
- Vietnam
- Canada
- Japan
- Hong Kong
- Australia
- Brazil
- India
- Malaysia
- New Zealand
- Philippines
- Russia
- Germany
- Mexico
- Indonesia
- Egypt
- Turkey
Aesthetic Injectables Pipeline Market Regulatory Paths Outlook
- PMA
- CE
- NMPA
- NIFDS
- 510(k)
- BOPA
- HSA
- MDITAC
- MDL
- MDCO
- ANVISA
- ICAC
- MDA
- Ninsho
- TGA
- Shonin
Scope
- Extensive coverage of the Aesthetic Injectables under development
- Reviews details of major pipeline reconstruction which include, product description, licensing and collaboration details, and other developmental activities
- Reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
- The coverage of pipeline reconstruction based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
- Identify and understand important and diverse types of Aesthetic Injectables under development
- Develop market-entry and market-expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date
Acro Biomedical Co Ltd
Advanced Aesthetic Technologies Inc
Aeon Astron Corporation
Aesthetic Medical Device
Allergan Aesthetics
Almirall Ltd
Beijing MeiYan KongJian Technology Co Ltd
BioPlus Co Ltd
Bioxis Pharmaceuticals
BMG Pharma SpA
Bmi Korea Co Ltd
CellPraxis
Celltrix AB
Collplant Biotechnologies Ltd
Dexlevo Inc
Dongkook Pharmaceutical Co Ltd
EternoGen Aesthetics LLC
Fillmed Laboratoires
G2GBIO Inc
Galderma SA
Genzyme Corp
Hallura Ltd
Histogen Inc
Hugel Inc
Innovia LLC
inSoma Bio Inc
Inventage Lab Inc
Jinwoo Bio Co Ltd
Juvenis Ltd
Khorionyx SA
Laboratoires Vivacy SAS
LG Chem Ltd
LifeSprout Inc
Medytox Inc
Merz North America Inc
Mesoestetic Pharma Group SL
Moma Therapeutics Inc
N8 Medical LLC
Oligo Medic Inc
PB&B SA
Peptron Inc
PetVivo Holdings Inc
Q-Med AB
RepliCel Life Sciences Inc
Samyang Biopharmaceuticals Corp
Sebana Medical Ltd
Shanghai Haohai Biological Technology Co Ltd
Shin Poong Pharm Co Ltd
Silk Medical Aesthetics Inc
Sinclair Pharma Ltd
Sofregen Medical Inc
SunMax Biotechnology Co Ltd
TEI Biosciences Inc
Tempo Therapeutics Inc
Teoxane SA
Tetratherix Pty Ltd
Tissueform Inc
University of California Santa Barbara
University of Missouri
Table of Contents
Frequently asked questions
-
Which segment has the highest number of pipeline reconstructions in the aesthetic injectables pipeline market as of May 2023?
As of May 2023, hyaluronic acid fillers has the highest number of pipeline products.
-
Which territory has the highest number of pipeline reconstructions in the aesthetic injectables pipeline market as of May 2023?
As of May 2023, the US has the highest number of pipeline reconstructions in the aesthetic Injectables pipeline market.
-
Which is the most followed regulatory pathway in the aesthetic injectables pipeline market As of May 2023?
As of May 2023, PMA is the most followed regulatory pathway in the aesthetic Injectables pipeline market.
-
Who are the major players operating in the aesthetic injectables pipeline market?
Some of the leading companies in the Aesthetic Injectables pipeline reconstruction market are AbbVie Inc, BioPlus Co Ltd, Celltrix AB, Galderma SA, Genzyme Corp, Medytox Inc, Teoxane SA, and Tissueform.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Aesthetic Injectables Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
